Abstract:ObjectivesTo comprehensively evaluate the glioma using quantitative susceptibility mapping (QSM).Materials and methodsForty-two patients (18 women; mean age, 45 years) with pathologically confirmed gliomas were retrospectively included. All the patients underwent conventional and advanced MRI examinations (QSM, DWI, MRS, etc.). Five patients underwent paired QSM (pre- and post-enhancement). Four Visually Accessible Rembrandt Image (VASARI) features and intratumoural susceptibility signal (ITSS) were observed. Three ROIs each were manually drawn separately in the tumour parenchyma with relatively high and low magnetic susceptibility. The association between the tumour’s magnetic susceptibility and other MRI parameters was also analysed.ResultsMorphologically, gliomas with heterogeneous ITSS were more similar to high-grade gliomas (p = 0.006, AUC: 0.72, sensitivity: 70%, and specificity: 73%). Heterogeneous ITSS was significantly associated with tumour haemorrhage, necrosis, diffusion restriction, and avid enhancement but did not change between pre- and post-enhanced QSM. Quantitatively, tumour parenchyma magnetic susceptibility had limited value in grading gliomas and identifying IDH mutation status, whereas the relatively low magnetic susceptibility of the tumour parenchyma helped identify oligodendrogliomas in IDH mutated gliomas (AUC = 0.78) with high specificity (100%). The relatively high tumour magnetic susceptibility significantly increased after enhancement (p = 0.039). Additionally, we found that the magnetic susceptibility of the tumour parenchyma was significantly correlated with ADC (r = 0.61) and Cho/NAA (r = 0.40).ConclusionsQSM is a promising candidate for the comprehensive evaluation of gliomas, except for IDH mutation status. The magnetic susceptibility of tumour parenchyma may be affected by tumour cell proliferation.Key Points• Morphologically, gliomas with a heterogeneous intratumoural susceptibility signal (ITSS) are more similar to high-grade gliomas (p = 0.006; AUC, 0.72; sensitivity, 70%; and specificity, 73%). Heterogeneous ITSS was significantly associated with tumour haemorrhage, necrosis, diffusion restriction, and avid enhancement but did not change between pre- and post-enhanced QSM.• Tumour parenchyma’s relatively low magnetic susceptibility helped identify oligodendroglioma with high specificity.• Tumour parenchyma magnetic susceptibility was significantly correlated with ADC (r = 0.61) and Cho/NAA (r = 0.40).

Role of susceptibility-weighted imaging and intratumoral susceptibility signals in grading and differentiating pediatric brain tumors at 1.5 T: a preliminary study

Application of SWI in Diagnosis and Differential Diagnosis of Hemangioma in Skeletal Muscle

Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions

Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging

Susceptibility-weighted imaging: The value in cerebral astrocytomas grading

Clinical Application of Susceptibility Weighted Imaging in Brain Tumors

Glioblastomas vs. Lymphomas: More Diagnostic Certainty by Using Susceptibility-Weighted Imaging (SWI)

Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas

Clinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a review

Susceptibility-weighted imaging in grading brain astrocytomas

A Pilot Study of Susceptibility Weighted Imaging in Grading Cerebral Gliomas

An update on susceptibility‐weighted imaging in brain gliomas

Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas

Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading

Molecular susceptibility weighted imaging of the glioma rim in a mouse model

Differentiation of grade II/III and grade IV glioma by combining “T1 contrast-enhanced brain perfusion imaging” and susceptibility-weighted quantitative imaging

Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging

Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation

Quantitative susceptibility mapping evaluation of glioma

Combining Amide Proton Transfer-Weighted and Arterial Spin Labeling Imaging to Differentiate Solitary Brain Metastases from Glioblastomas

Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form